// company-profile

Taysha Gene Therapies, Inc.

TSHA
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings54Insiders10
// api This Taysha Gene Therapies, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 8 insiders purchased shares. Buying was led by Stalfort John A III.

// 90-day insight

Over the last 90 days, Taysha Gene Therapies, Inc. insiders bought $33K across 10 transactions with no open-market sales.

  • Most active insider: Nagendran Sukumar with 3 transactions totaling $925K.
  • Largest single sale: $892K by Nagendran Sukumar on Apr 10, 2026.
  • 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Taysha Gene Therapies, Inc. as of 2026-03-31

↓ decreasing
Total reported AUM
$1.18B
QoQ change
-14.5%
Reporting period
2026-03-31
#1
RA CAPITAL MANAGEMENT, L.P.
CIK 1346824
$105.3M
23.6M shares
#2
Avoro Capital Advisors LLC
CIK 1633313
$97.0M
21.7M shares
#3
Vestal Point Capital, LP
CIK 1974915
$80.5M
18.0M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 1, 2026Stalfort John A IIITSHA
Award
42,671$0.00$0K
Jun 1, 2026Donenberg Phillip B.TSHA
Award
42,671$0.00$0K
Jun 1, 2026Donenberg Phillip B.TSHA
Award
21,335$0.00$0K
Jun 1, 2026Long Alison STSHA
Award
21,335$0.00$0K
Jun 1, 2026Long Alison STSHA
Award
42,671$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.